Back to Results
First PageMeta Content
Ottawa Hospital Research Institute / Cancer research / Yale Cancer Center / John Cameron Bell / Cancer organizations / Medicine / Ontario Institute for Cancer Research


OICR congratulates Dr. John Bell on the announcement of BioCanRX, a new Canadian cancer biotherapeutics initiative TORONTO, ON (December 16, 2014) – Dr. Tom Hudson, President and Scientific Director of the Ontario Inst
Add to Reading List

Document Date: 2014-12-16 14:38:14


Open Document

File Size: 311,50 KB

Share Result on Facebook

City

TORONTO / /

Company

OICR / /

Country

Canada / /

Currency

USD / /

/

Facility

Ottawa Hospital Research Institute / University of Ottawa / Ontario Institute / The Ottawa Hospital / /

IndustryTerm

bio-computing / treatment of cancer / Cancer Treatment / manufacturing / anti-cancer bio-therapeutic products / imaging / /

MedicalCondition

cancer / Canadian cancer / innovative cancer / /

Organization

Program / Government of Canada / Ottawa Hospital / Ontario Institute for Cancer Research / University of Ottawa / Ontario government / Cancer Treatment / Ottawa Hospital Research Institute / Government of Ontario / /

Person

Tom Hudson / John Bell / Neil Berinstein / Christopher Needles / /

/

Position

Director / President and Scientific Director / Manager / Strategic Communications Email / Director of Translational Research / Scientist / professor of Medicine / /

ProvinceOrState

Ontario / /

PublishedMedium

Cancer Research / /

Technology

genomics / antibodies / stem cells / /

URL

www.oicr.on.ca / /

SocialTag